Immunocore Holdings plc
IMCR
$33.97
-$0.50-1.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -106.23% | 143.15% | -16,883.05% | 98.28% | -305.06% |
| Total Depreciation and Amortization | 8.23% | 13.67% | 4.51% | 2.31% | -8.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 277.65% | -90.72% | 730.78% | -142.90% | 303.51% |
| Change in Net Operating Assets | 124.80% | -10.29% | -1,946.98% | -104.95% | 451.33% |
| Cash from Operations | 215.63% | 57.82% | -632.83% | -117.16% | 5,868.74% |
| Capital Expenditure | 55.87% | 38.16% | -285.03% | -80.68% | -38.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 200.00% | -66.67% | 120.00% | -400.00% |
| Cash from Investing | -118.63% | 579.43% | -116.76% | 117.27% | -413.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,412.96% | -84.69% | 129.58% | -49.16% | 43.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,412.96% | -84.69% | 129.58% | -49.16% | 43.87% |
| Foreign Exchange rate Adjustments | 110.07% | -322.16% | -118.59% | -34.13% | 40.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 314.48% | 51.04% | -392.98% | -5.48% | -47.49% |